Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) Return on Sales (2020 - 2025)

Sotera Health has reported Return on Sales over the past 6 years, most recently at 0.11% for Q4 2025.

  • Quarterly results put Return on Sales at 0.11% for Q4 2025, up 7.0% from a year ago — trailing twelve months through Dec 2025 was 0.07% (up 3.0% YoY), and the annual figure for FY2025 was 0.07%, up 3.0%.
  • Return on Sales for Q4 2025 was 0.11% at Sotera Health, down from 0.16% in the prior quarter.
  • Over the last five years, Return on Sales for SHC hit a ceiling of 0.17% in Q2 2021 and a floor of 1.27% in Q4 2022.
  • Median Return on Sales over the past 5 years was 0.08% (2024), compared with a mean of 0.01%.
  • Biggest five-year swings in Return on Sales: surged 453bps in 2021 and later plummeted -142bps in 2022.
  • Sotera Health's Return on Sales stood at 0.15% in 2021, then crashed by -952bps to 1.27% in 2022, then surged by 110bps to 0.12% in 2023, then tumbled by -66bps to 0.04% in 2024, then soared by 170bps to 0.11% in 2025.
  • The last three reported values for Return on Sales were 0.11% (Q4 2025), 0.16% (Q3 2025), and 0.03% (Q2 2025) per Business Quant data.